The anti-adhesive mucin podocalyxin may help initiate the transperitoneal metastasis of high grade serous ovarian carcinoma

Clinical and Experimental Metastasis

Volumn 29, Issue 3, 2012, Pages 239-252

  Cipollone, Jane A ^a   Graves, Marcia L ^a   Köbel, Martin ^b   Kalloger, Steve E ^c   Poon, Tak ^a   Gilks, C Blake ^c   McNagny, Kelly M ^a   Roskelley, Calvin D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

Adhesion; Marker; Ovarian cancer; Progression

Indexed keywords

BETA1 INTEGRIN; FIBRONECTIN; PODOCALYXIN;

ADULT; AGED; APICAL MEMBRANE; ARTICLE; BASEMENT MEMBRANE; CANCER CELL CULTURE; CANCER GRADING; CELL ADHESION; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MONOLAYER CULTURE; OVARY CARCINOMA; PERITONEUM METASTASIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TISSUE MICROARRAY;

ANTIGENS, CD29; CELL ADHESION; CELL LINE, TUMOR; CYSTADENOMA, SEROUS; ENDOMETRIUM; FALLOPIAN TUBES; FEMALE; HUMANS; OVARIAN NEOPLASMS; OVARY; PERITONEAL NEOPLASMS; SIALOGLYCOPROTEINS;

EID: 84857356635     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-011-9446-0     Document Type: Article

References (50)

1. A Jemal RC Tiwari T Murray A Ghafoor A Samuels E Ward EJ Feuer MJ Thun American Cancer Society 2004 Cancer statistics CA Cancer J Clin 54 8 29 14974761 10.3322/canjclin.54.1.8
2. EL Trimble J Davis P Disaia K Fujiwara D Gaffney G Kristensen J Ledermann J Pfisterer M Quinn N Reed M Schoenfeldt JT Thigpen Gynecologic Cancer Intergroup 2007 Clinical trials in gynecological cancer Int J Gynecol Cancer 17 3 547 556 17504371 10.1111/j.1525-1438.2007.00667.x 1:STN:280: DC%2BD2s3ptlKiug%3D%3D (Pubitemid 46743989)
3. F Flam N Einhorn K Sjovall 1988 Symptomatology of ovarian cancer Eur J Obstet Gynecol Reprod Biol 27 53 57 3338609 10.1016/S0028-2243(88)80010-8 1:STN:280:DyaL1c7ht1Cgtg%3D%3D
4. B Davidson B Risberg R Reich A Berner 2003 Effusion cytology in ovarian cancer: new molecular methods as aids to diagnosis and prognosis Clin Lab Med 23 729 754 14560537 10.1016/S0272-2712(03)00058-1 (Pubitemid 37175552)
5. WM Schopperle DB Kershaw WC DeWolf 2003 Human embryonal carcinoma tumor antigen, Gp200/GCTM-2, is podocalyxin Biochem Biophys Res Commun 300 2 285 290 12504081 10.1016/S0006-291X(02)02844-9 (Pubitemid 38375807)
6. TW Kelley D Huntsman KM McNagny CD Roskelley ED Hsi 2005 Podocalyxin: a marker of blasts in acute leukemia Am J Clin Pathol 124 1 134 142 15923169 10.1309/7BHLAHHU0N4MHT7Q (Pubitemid 40944386)
7. JT Ney H Zhou B Sipos R Buttner X Chen G Kloppel I Gutgemann 2007 Podocalyxin-like protein 1 expression is useful to differentiate pancreatic ductal adenocarcinomas from adenocarcinomas of the biliary and gastrointestinal tracts Hum Pathol 38 2 359 364 17137615 10.1016/j.humpath.2006.08.025 1:CAS:528:DC%2BD2sXnslOgsw%3D%3D (Pubitemid 46096563)
8. WM Schopperle WC DeWolf 2007 The TRA-1-60 and TRA-1-81 human pluripotent stem cell markers are expressed on podocalyxin in embryonal carcinoma Stem Cells 25 3 723 730 17124010 10.1634/stemcells.2005-0597 1:CAS:528: DC%2BD2sXktlehu7c%3D (Pubitemid 46354232)
9. H Yasuoka M Tsujimoto M Hirokawa M Tori M Nakahara A Miyauchi R Kodama T Sanke Y Nakamura 2008 Podocalyxin expression in undifferentiated thyroid carcinomas J Clin Pathol 61 11 1228 1229 18955579 10.1136/jcp.2008.059956 1:STN:280:DC%2BD1cnovFCqtA%3D%3D
10. SN Thomas RL Schnaar K Konstantopoulos 2009 Podocalyxin-like protein is an E-/L-selectin ligand on colon carcinoma cells: comparative biochemical properties of selectin ligands in host and tumor cells Am J Physiol Cell Physiol 296 3 C505 C513 19118161 10.1152/ajpcell.00472.2008 1:CAS:528: DC%2BD1MXjtFGrsLc%3D
11. YH Hsu WL Lin YT Hou YS Pu CT Shun CL Chen YY Wu JY Chen TH Chen TS Jou 2010 Podocalyxin EBP50 ezrin molecular complex enhances the metastatic potential of renal cell carcinoma through recruiting Rac1 guanine nucleotide exchange factor ARHGEF7 Am J Pathol 176 6 3050 3061 20395446 10.2353/ajpath.2010.090539 1:CAS:528:DC%2BC3cXptFKrtrs%3D
12. G Casey PJ Neville X Liu SJ Plummer MS Cicek LM Krumroy AP Curran MR McGreevy WJ Catalona EA Klein JS Witte 2006 Podocalyxin variants and risk of prostate cancer and tumor aggressiveness Hum Mol Genet 15 5 735 741 16434482 10.1093/hmg/ddi487 1:CAS:528:DC%2BD28XhsF2mtbg%3D (Pubitemid 43264698)
13. A Somasiri JS Nielsen N Makretsov ML McCoy L Prentice CB Gilks SK Chia KA Gelmon DB Kershaw DG Huntsman KM McNagny CD Roskelley 2004 Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression Cancer Res 64 15 5068 5073 15289306 10.1158/0008-5472.CAN-04-0240 1:CAS:528:DC%2BD2cXmtF2mt7w%3D (Pubitemid 39006520)
14. H-H Cheung AJ Davis T-L Lee AL Pang S Nagrani OM Rennert W-Y Chan 2011 Methylation of an intronic region regulates miR-199a in testicular tumor malignancy Oncogene 30 31 3404 3415 21383689 10.1038/onc.2011.60 1:CAS:528:DC%2BC3MXivVSmsL4%3D
15. D Kerjaschki DJ Sharkey MG Farquhar 1984 Identification and characterization of podocalyxin-the major sialoprotein of the renal glomerular epithelial cell J Cell Biol 98 1591 1596 6371025 10.1083/jcb.98.4.1591 1:CAS:528:DyaL2cXhvVOmu7g%3D (Pubitemid 14126988)
16. G Dekan A Miettinen E Schnabel MG Farquhar 1990 Binding of monoclonal antibodies to glomerular endothelium, slit membranes, and epithelium after in vivo injection. Localization of antigens and bound IgGs by immunoelectron microscopy Am J Pathol 137 4 913 927 1977320 1:STN:280:DyaK3M%2Fit12rug%3D%3D (Pubitemid 20337806)
17. R Doyonnas DB Kershaw C Duhme H Merkens S Chelliah T Graf KM McNagny 2001 Anuria, omphalocele, and perinatal lethality in mice lacking the CD-34-related protein podocalyxin J Exp Med 194 13 27 11435469 10.1084/jem.194.1.13 1:CAS:528:DC%2BD3MXkvFWitLg%3D (Pubitemid 32660434)
18. A Miettinen ML Solin J Reivinen E Juvonen R Vaisanen H Holthofer 1999 Podocalyxin in rat platelets and megakaryocytes Am J Pathol 154 3 813 822 10079259 10.1016/S0002-9440(10)65328-X 1:CAS:528:DyaK1MXitVeltbo%3D (Pubitemid 29122600)
19. N Vitureira K McNagny E Soriano F Burgaya 2005 Pattern of expression of the podocalyxin gene in the mouse brain during development Gene Expr Patterns 5 3 349 354 15661640 10.1016/j.modgep.2004.10.002 1:CAS:528:DC%2BD2MXms1CgsQ%3D%3D (Pubitemid 40124549)
20. D Meder A Shevchenko K Simons J Füllekrug 2005 Gp135/podocalyxin and NHERF-2 participate in the formation of a preapical domain during polarization of MDCK cells J Cell Biol 168 2 303 313 15642748 10.1083/jcb.200407072 1:CAS:528:DC%2BD2MXlvVGgsg%3D%3D (Pubitemid 40248227)
21. JS Nielsen M McCoy S Chelliah AW Vogl CD Roskelley KM McNagny 2007 The CD34-related molecule podocalyxin is a potent inducer of microvillus formation PLoS ONE 2 e237 17311105 10.1371/journal.pone.0000237
22. B Strilic T Kucera J Eglinger MR Hughes KM McNagny S Tsukita E Dejana E Ferrara Lammert 2009 The molecular basis of vascular lumen formation in the developing mouse aorta Dev Cell 17 4 505 515 19853564 10.1016/j.devcel.2009.08. 011 1:CAS:528:DC%2BD1MXhsVChtLvF
23. N Auersperg AS Wong KC Choi SK Kang PC Leung 2001 Ovarian surface epithelium: biology, endocrinology, and pathology Endocr Rev 22 2 255 288 11294827 10.1210/er.22.2.255 1:CAS:528:DC%2BD3MXjsFSntLs%3D (Pubitemid 32458162)
24. RJ Kurman IeM Shih 2010 The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory Am J Surg Pathol 34 3 433 443 20154587 10.1097/PAS.0b013e3181cf3d79
25. E Jarboe A Folkins MR Nucci D Kindelberger R Drapkin A Miron Y Lee CP Crum 2008 Serous carcinogenesis in the fallopian tube: a descriptive classification Int J Gynecol Pathol 27 1 1 9 18156967 10.1097/pgp. 0b013e31814b191f (Pubitemid 351627965)
26. DB Kershaw SG Beck BL Wharram JE Wiggins M Goyal PE Thomas RC Wiggins 1997 Molecular cloning and characterization of human podocalyxin-like protein J Biol Chem 272 25 15708 15714 9188463 10.1074/jbc.272.25.15708 1:CAS:528:DyaK2sXktFCntbg%3D (Pubitemid 27265543)
27. CB Gilks DN Ionescu SE Kalloger M Köbel J Irving B Clarke J Santos N Le V Moravan K Swenerton Cheryl Brown Ovarian Cancer Outcomes Unit of the British Columbia Cancer Agency 2008 Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma Hum Pathol 39 8 1239 1251 18602670 10.1016/j.humpath.2008.01.003 1:CAS:528:DC%2BD1cXptVKrsLw%3D
28. M Köbel SE Kalloger N Boyd S McKinney E Mehl C Palmer S Leung NJ Bowen DN Ionescu A Rajput LM Prentice D Miller J Santos K Swenerton CB Gilks D Huntsman 2008 Ovarian carcinoma subtypes are different diseases: implications for biomarker studies PLoS Med 5 12 e232 19053170 10.1371/journal.pmed.0050232
29. ML Graves L Zhou G MacDonald CR Mueller CD Roskelley 2007 Regulation of the BRCA1 promoter in ovarian surface epithelial cells and ovarian carcinoma cells FEBS Lett 581 9 1825 1833 17434164 10.1016/j.febslet.2007.03.072 1:CAS:528:DC%2BD2sXksV2rt74%3D (Pubitemid 46602276)
30. ND Connell JG Rheinwald 1983 Regulation of the cytoskeleton in mesothelial cells: reversible loss of keratin and increase in vimentin during rapid growth in culture Cell 34 1 245 253 6192933 10.1016/0092-8674(83)90155-1 1:CAS:528:DyaL3sXltF2qtb4%3D (Pubitemid 13045474)
31. J Pinkas P Leder 2002 Mek1 signaling mediates transformation and metastasis of EpH4 mammary epithelial cells independent of epithelial to mesenchymal transition Cancer Res 62 4781 4790 12183438 1:CAS:528: DC%2BD38XmsVShsbY%3D
32. TC Hamilton RC Young WM McKoy KR Grotzinger JA Green EW Chu J Whang-Peng AM Rogan WR Green RF Ozols 1983 Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors Cancer Res 43 11 5379 5389 6604576 1:CAS:528:DyaL2cXhtlahsb0%3D (Pubitemid 14230154)
33. SA Cannistra C Ottensmeier J Niloff B Orta J DiCarlo 1995 Expression and function of β1 and αvβ3 integrins in ovarian cancer Gynecol Oncol 58 216 225 7542622 10.1006/gyno.1995.1214 1:CAS:528:DyaK2MXntlamtrY%3D
34. S Rangarajan JM Enserink HB Kuiperij J de Rooij LS Price F Schwede JL Bos 2003 Cyclic AMP induces integrin-mediated adhesion through Epac and Rap1 upon stimulation of the β2-adrenergic receptor J Cell Biol 160 487 493 12578910 10.1083/jcb.200209105 1:CAS:528:DC%2BD3sXhsVOls70%3D (Pubitemid 36254387)
35. T Takeda WY Go RA Orlando MG Farquhar 2000 Expression of podocalyxin inhibits cell-cell adhesion and modifies junctional properties in madin-Darby Canine Kidney Cells Mol Biol Cell 11 3219 3232 10982412 1:CAS:528: DC%2BD3cXmvFShsrc%3D (Pubitemid 32107095)
36. KM Abdullah EA Udoh PE Shewen A Mellors 1992 A neutral glycoprotease of Pasteurella haemolytica A1 specifically cleaves O-sialoglycoproteins Infect Immun 60 56 62 1729196 1:CAS:528:DyaK38XktVejtLY%3D
37. KM Burleson RC Casey KM Skubitz SE Pambuccian TR Oegema Jr AP Skubitz 2004 Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers Gynecol Oncol 93 1 170 181 15047232 10.1016/j.ygyno.2003.12.034 1:CAS:528:DC%2BD2cXisFylurg%3D (Pubitemid 38429567)
38. CP Crum R Drapkin A Miron TA Ince M Muto DW Kindelberger Y Lee 2007 The distal fallopian tube: a new model for pelvic serous carcinogenesis Curr Opin Obstet Gynecol 19 1 3 9 17218844 10.1097/GCO.0b013e328011a21f (Pubitemid 46095865)
39. MJ Callahan CP Crum F Medeiros DW Kindelberger JA Elvin JE Garber CM Feltmate RS Berkowitz MG Muto 2007 Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction J Clin Oncol 25 25 3985 3990 17761984 10.1200/JCO.2007.12.2622 (Pubitemid 47477278)
40. J Fountain E Trimble MJ Birrer 2006 Summary and discussion of session recommendations Gynecol Oncol 103 2, Suppl 1 S23 S25 17027068 10.1016/j.ygyno.2006.08.022 (Pubitemid 44633413)
41. SS Francis J Sfakianos B Lo I Mellman 2011 A hierarchy of signals regulates entry of membrane proteins into the ciliary membrane domain in epithelial cells J Cell Biol 193 219 233 21444686 10.1083/jcb.201009001 1:CAS:528:DC%2BC3MXkslalsr4%3D
42. Y Li J Li SW Straight DB Kershaw 2002 PDZ domain-mediated interaction of rabbit podocalyxin and Na(+)/H(+) exchange regulatory factor-2 Am J Physiol Renal Physiol 282 F1129 F1139 11997330 1:CAS:528:DC%2BD38Xks12ms7k%3D
43. PC Tan SG Furness H Merkens S Lin ML McCoy CD Roskelley J Kast KM McNagny 2006 Na+/H+ exchanger regulatory factor-1 is a hematopoietic ligand for a subset of the CD34 family of stem cell surface proteins Stem Cells 24 1150 1161 16410385 10.1634/stemcells.2005-0426 1:CAS:528:DC%2BD28XhtFGhu7bM (Pubitemid 44464683)
44. RA Orlando T Takeda B Zak S Schmieder VM Benoit T McQuistan H Furthmayr MG Farquhar 2001 The glomerular epithelial cell anti-adhesin podocalyxin associates with the actin cytoskeleton through interactions with ezrin J Am Soc Nephrol 12 1589 1598 11461930 1:CAS:528:DC%2BD3MXlvVCkuro%3D (Pubitemid 32674420)
45. T Takeda T McQuistran RA Orlando MG Farquhar 2001 Loss of glomerular foot processes is associated with uncoupling of podocalyxin from the actin cytoskeleton J Clin Invest 108 289 301 11457882 1:CAS:528:DC%2BD3MXlt1Kltrs%3D (Pubitemid 32656253)
46. S Sizemore M Cicek N Sizemore KP Ng G Casey 2007 Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin Cancer Res 67 13 6183 6191 17616675 10.1158/0008-5472.CAN-06-3575 1:CAS:528:DC%2BD2sXnsVyqtrs%3D (Pubitemid 47037499)
47. X Meng P Ezzati JA Wilkins 2011 Requirement of podocalyxin in TGF-beta induced epithelial mesenchymal transition PLoS ONE 6 4 e18715 21533279 10.1371/journal.pone.0018715 1:CAS:528:DC%2BC3MXltV2lsrw%3D
48. M Kobel E Gradhand K Zeng WD Schmitt K Kriese T Lantzsch M Wolters J Dittmer HG Strauss C Thomssen S Hauptmann 2006 Ezrin promotes ovarian carcinoma cell invasion and its retained expression predicts poor prognosis in ovarian carcinoma Int J Gynecol Pathol 25 2 121 130 16633060 10.1097/01.pgp.0000185410. 39050.ac (Pubitemid 44620173)
49. AD Tabrizi SE Kalloger M Köbel J Cipollone CD Roskelley E Mehl CB Gilks 2010 Primary ovarian mucinous carcinoma of intestinal type: significance of pattern of invasion and immunohistochemical expression profile in a series of 31 cases Int J Gynecol Pathol 29 2 99 107 20173494 10.1097/PGP.0b013e3181bbbcc1
50. C Klausen PC Leung N Auersperg 2009 Cell motility and spreading are suppressed by HOXA4 in ovarian cancer cells: possible involvement of β1 integrin Mol Cancer Res 7 9 1425 1437 19723874 10.1158/1541-7786.MCR-08-0466 1:CAS:528:DC%2BD1MXhtFCjtbrL